Rare meets rarer: anti-synthetase syndrome in a patient with facio-scapulo-humeral muscular dystrophy-Reference-Cited by-同舟云学术

Rare meets rarer: anti-synthetase syndrome in a patient with facio-scapulo-humeral muscular dystrophy

Published:2022-06-01 Issue:12 Volume:61 Page:e368-e370
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Valor-Méndez Larissa¹²^ORCID,Manger Bernhard²³^ORCID,Winterholler Martin⁴,Schett Georg²³,Türk Mattias⁵,Knitza Johannes²³^ORCID

Affiliation:

1. Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen , Erlangen, Germany

2. Deutsches Zentrum für Immuntherapie (DZI)

3. Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen , Erlangen

4. Neurologische Klinik, Sana-Krankenhaus Rummelsberg , Schwarzenbruck

5. Department of Neurology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen , Erlangen, Germany

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/keac328/44251386/keac328.pdf

Reference8 articles.

1. FSHD1 or FSHD2: hat is the question: the answer: it's all just FSHD;Johnson;Neurology,2019

2. Relationship between muscle inflammation and fat replacement assessed by MRI in facioscapulohumeral muscular dystrophy;Dahlqvist;J Neurol,2019

3. Defining anti-synthetase syndrome: a systematic literature review;Zanframundo;Clin Exp Rheumatol,2022

4. Rituximab in the treatment of inflammatory myopathies: a review;Fasano;Rheumatology (Oxford),2017

5. Facioscapulohumeral muscular dystrophy: update on pathogenesis and future treatments;Hamel;Neurotherapeutics,2018